Last reviewed · How we verify

Levamisol — Competitive Intelligence Brief

Levamisol (LEVAMISOLE) competitive landscape: 3 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: levamisole. Area: Other.

marketed levamisole Alkaline phosphatase, tissue-nonspecific isozyme Other Small molecule Live · refreshed every 30 min

Target snapshot

Levamisol (LEVAMISOLE).

Comparator set (3 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Levamisol TARGET LEVAMISOLE marketed levamisole Alkaline phosphatase, tissue-nonspecific isozyme 1990-01-01
Oxtriphylline choline theophyllinate Warner Chilcott Llc marketed choline theophyllinate Adenosine receptor A3, Alkaline phosphatase, tissue-nonspecific isozyme, Adenosine receptor A1 1981-01-01
Aminophyllin Aminophyllin University of Padova marketed Adenosine receptor A3, Alkaline phosphatase, tissue-nonspecific isozyme, Adenosine receptor A1
Theophyllin Theophyllin University of Bergen marketed Adenosine receptor A3, Alkaline phosphatase, tissue-nonspecific isozyme, Adenosine receptor A1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (levamisole class)

  1. · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Levamisol — Competitive Intelligence Brief. https://druglandscape.com/ci/levamisole. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators: